Why the study?
Current disease notation for cardiomyopathies has limitations regarding the integration of new knowledge about aetiology.
Key points are not available for this paper at this time.
Design
Review
Supports multiparametric cardiomyopathy classification; hypothesis-generating and requires prospective validation before practice change.
PURPOSE OF REVIEW: The aim of this paper is to briefly summarise the clinical approach to disease notation for cardiomyopathies and to highlight its limitations with respect to the integration of new knowledge about aetiology. RECENT FINDINGS: The paper uses the recently advocated concept of arrhythmogenic cardiomyopathy as an example of the limitations of current classification systems. At present, there is no single classification system that meets the needs of all potential users, whether they are basic scientists, clinicians, patients or families. The classical cardiomyopathy subtypes still have utility, but future disease notation needs to be modified to take into account the new and more complete phenotypes and aetiologies.
No takes yet. Share an insight, caveat, or question.
Perry Elliott (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: